Kevad Bio is dedicated towards the discovery and development of novel medicines for the treatment of diseases of nerves.
We are building a pipeline of neurotrophic small molecules to treat brain, spinal cord, intestinal and ophthalmic neurological disorders.
Our platform has broad applications that span both rare and prevalent diseases. The primary indication is Parkinson’s disease.
Learn more about our science
Our platform is built upon extensive research in neurotrophic factors conducted by our partner Prof. Saarma at the University of Helsinki.
Learn more about our team